Skip Nav Destination
Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b
The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia
Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial
JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia
Issue Archive
January 15 2001
Table of Contents
INSIDE BLOOD
REVIEW ARTICLES
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b
Clinical Trials & Observations
Stanley Calderwood,Laurie Kilpatrick,Steven D. Douglas,Melvin Freedman,Kim Smith-Whitley,Martha Rolland,Joanne Kurtzberg
The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings
Clinical Trials & Observations
Alvaro Urbano-Ispizua,Ciril Rozman,Pedro Pimentel,Carlos Solano,Javier de la Rubia,Salut Brunet,Jaime Pérez-Oteiza,Christelle Ferrá,Javier Zuazu,Dolores Caballero,Alzira Carvalhais,Jose Luis Dı́ez,Ildefonso Espigado,Carmen Martı́nez,Fernando Campilho,Miguel Angel Sanz,Jorge Sierra,Javier Garcı́a-Conde,Emilio Montserrat,for the Spanish Group for Allogeneic Peripheral Blood Transplantation
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
Clinical Trials & Observations
Per Ljungman,Giorgio Lambertenghi Deliliers,Uwe Platzbecker,Susanne Matthes-Martin,Andrea Bacigalupo,Hermann Einsele,Johanna Ullmann,Maurizio Musso,Rudolf Trenschel,Patricia Ribaud,Martin Bornhäuser,Simone Cesaro,Bruce Crooks,Adrian Dekker,Nicole Gratecos,Thomas Klingebiel,Elena Tagliaferri,Andrew J. Ullmann,Pierre Wacker,Catherine Cordonnier,for the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia
Clinical Trials & Observations
Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis
Clinical Trials & Observations
Brigitte Bader-Meunier,Frédéric Gauthier,Frédérique Archambaud,Thérèse Cynober,Francoise Miélot,Jean-Paul Dommergues,Josiane Warszawski,Narla Mohandas,Gil Tchernia
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial
Clinical Trials & Observations
Sandra J. Horning,Robert S. Negrin,Richard T. Hoppe,Saul A. Rosenberg,Nelson J. Chao,Gwynn D. Long,B. William Brown,Karl G. Blume
GENE THERAPY
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
NEOPLASIA
Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription
Harald Stein,Theresa Marafioti,Hans-Dieter Foss,Helmut Laumen,Michael Hummel,Ioannis Anagnostopoulos,Thomas Wirth,Gudrun Demel,Brunangelo Falini
JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia
Clinical Trials & Observations
RED CELLS
TRANSFUSION MEDICINE
TRANSPLANTATION
Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-β–treated alloreactive T cells that do not induce graft-versus-host disease
Vassiliki A. Boussiotis,Zong-Ming Chen,Jay C. Zeller,William J. Murphy,Alla Berezovskaya,Satwant Narula,Maria G. Roncarolo,Bruce R. Blazar
BRIEF REPORTS
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals